{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:48:00Z","timestamp":1780440480458,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstact<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronavirus disease (COVID-19) currently named SARS-CoV-2 is a contagious disease caused by a coronavirus; incompatible data are present on the possible relationship among COVID-19 vaccines and hair loss.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>The objective of the current study was to assess dermoscopically the prevalence of hair loss among an Egyptian population following COVID-19 vaccination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 2000 participants were enrolled in this cross-sectional study. Adult males and females who received one of recognized COVID-19 vaccine were included, irrespective of the status of previous COVID-19 infection. Those who were aged less than 18\u00a0years or above 60\u00a0years were excluded. Furthermore, subjects self-reporting hair loss were assessed by dermoscopy. <\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the studied cases, n\u2009=\u2009478 (23.9%) complained of hair loss following vaccination. The majority of cases noticed their hair loss during the first 2\u00a0months post-vaccination (n\u2009=\u2009215 after the first month and n\u2009=\u2009158 after the 2nd month respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We reported prevalence of post-vaccination hair fall that was confirmed by trichoscopy and which affected approximately one quarter of participants who received COVID-19 vaccines. Other factors, such as stress and infection, cannot be excluded and remain to be further investigated by larger multicenter studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11845-023-03493-5","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:01:50Z","timestamp":1692057710000},"page":"755-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study"],"prefix":"10.1007","volume":"193","author":[{"given":"Amr M.","family":"Ammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas N.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-5241","authenticated-orcid":false,"given":"Mohamed L.","family":"Elsaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"issue":"2","key":"3493_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000528719","volume":"9","author":"L Genco","year":"2023","unstructured":"Genco L, Cantelli M, Noto M et al (2023) Alopecia areata after COVID-19 vaccines. Skin Appendage Disord 9(2):141\u2013143","journal-title":"Skin Appendage Disord"},{"issue":"2","key":"3493_CR2","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/vaccines11020444","volume":"11","author":"J Hern\u00e1ndez Arroyo","year":"2023","unstructured":"Hern\u00e1ndez Arroyo J, Izquierdo-Condoy JS, Ortiz-Prado E (2023) A case series and literature review of telogen effluvium and alopecia universalis after the administration of a heterologous COVID-19 vaccine scheme. Vaccines (Basel) 11(2):444","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"3493_CR3","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1111\/jocd.15328","volume":"21","author":"AM Ammar","year":"2022","unstructured":"Ammar AM, Elshahid AR, Abdel-Dayem HA et al (2022) Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: a cross sectional-comparative study. J Cosmet Dermatol 21(11):5790\u20135799","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"3493_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13666","volume":"33","author":"ML Elsaie","year":"2020","unstructured":"Elsaie ML, Youssef EA, Nada HA (2020) Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther 33(4):e13666","journal-title":"Dermatol Ther"},{"issue":"2","key":"3493_CR5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/09546634.2020.1782823","volume":"33","author":"ML Elsaie","year":"2022","unstructured":"Elsaie ML, Nada HA (2022) Herpes zoster (shingles) complicating the course of COVID19 infection. J Dermatolog Treat 33(2):1123\u20131125","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"3493_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/vaccines9050502","volume":"9","author":"I J\u0119\u015bkowiak","year":"2021","unstructured":"J\u0119\u015bkowiak I, Wiatrak B, Grosman-Dziewiszek P et al (2021) The incidence and severity of post-vaccination reactions after vaccination against COVID-19. Vaccines, NCBI 9(5):502","journal-title":"Vaccines, NCBI"},{"issue":"7","key":"3493_CR7","first-page":"4663","volume":"9","author":"W AlSahli","year":"2022","unstructured":"AlSahli W, Almulhim Y, Issa NT (2022) Cross-sectional study to determine the prevalence of telogen effluvium among patients experiencing COVID-19 infection or vaccination in Saudi Arabia and Arabic countries. European Journal of Molecular & Clinical Medicine 9(7):4663\u20134674","journal-title":"European Journal of Molecular & Clinical Medicine"},{"issue":"10","key":"3493_CR8","doi-asserted-by":"publisher","first-page":"6056","DOI":"10.4103\/jfmpc.jfmpc_377_22","volume":"11","author":"M Alharbi","year":"2022","unstructured":"Alharbi M (2022) Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia. J Family Med Prim Care 11(10):6056\u20136060","journal-title":"J Family Med Prim Care"},{"issue":"6","key":"3493_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13923","volume":"33","author":"D Turkmen","year":"2020","unstructured":"Turkmen D, Altunisik N, Sener S, Colak C (2020) Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire. Dermatol Ther 33(6):e13923","journal-title":"Dermatol Ther"},{"issue":"9","key":"3493_CR10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/vaccines10091467","volume":"10","author":"F Tassone","year":"2022","unstructured":"Tassone F, Cappilli S, Antonelli F et al (2022) Alopecia areata occurring after COVID-19 vaccination: a single-center, cross-sectional study. Vaccines 10(9):1467","journal-title":"Vaccines"},{"issue":"2","key":"3493_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/jocd.14117","volume":"21","author":"ML Elsaie","year":"2022","unstructured":"Elsaie ML, Hasan MS (2022) Successful treatment of long-standing alopecia totalis with intralesional methotrexate. J Cosmet Dermatol 21(2):855\u2013856","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"3493_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/jocd.15546","volume":"22","author":"AR Elshahid","year":"2023","unstructured":"Elshahid AR, Kadah AS, Hassan EA, Elsaie ML (2023) Efficacy of Jessener solution versus intralesional steroid in treatment of alopecia areata. J Cosmet Dermatol 22(2):529\u2013533","journal-title":"J Cosmet Dermatol"},{"issue":"12","key":"3493_CR13","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1111\/jocd.14459","volume":"20","author":"R Essam","year":"2021","unstructured":"Essam R, Ehab R, Al-Razzaz R (2021) Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford\/AstraZeneca): a potential triggering factor? J Cosmet Dermatol 20(12):3727\u20133729","journal-title":"J Cosmet Dermatol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03493-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03493-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03493-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T03:57:21Z","timestamp":1711339041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03493-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3493"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03493-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by ethics committee on human research by Al Azhar faculty of medicine IRB (00012367\u201319\u201307\u2013012). All methods were performed in accordance with the relevant guidelines and regulations. Written informed consents were received from participants upon explanation of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; the manuscript does not contain any individual personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}